GlaxoSmithKline plc (GSKN) — Free Cash Flow Generation Index
GlaxoSmithKline plc (GSKN) has a Free Cash Flow Generation Index of 0.60x as of September 2025. Free cash flow of MX$1.34 Billion represents 1% of operating cash flow (MX$2.22 Billion). See GlaxoSmithKline plc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline plc Free Cash Flow Generation Index (2013–2024)
Historical FCF Generation Index trend for GlaxoSmithKline plc across 12 annual periods. Explore GlaxoSmithKline plc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for GlaxoSmithKline plc (2013–2024)
Year-by-year Free Cash Flow Generation Index for GlaxoSmithKline plc. For the full company profile including market capitalisation, see GSKN market cap.
| Year | FCG Index | Free Cash Flow (MXN) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | MX$3.57 Billion | MX$6.55 Billion | MX$2.98 Billion | ▼ -5.7% |
| 2023 | 0.58x | MX$3.17 Billion | MX$5.48 Billion | MX$2.31 Billion | ▼ -16.9% |
| 2022 | 0.69x | MX$5.14 Billion | MX$7.40 Billion | MX$1.14 Billion | ▲ +10.1% |
| 2021 | 0.63x | MX$5.02 Billion | MX$7.95 Billion | MX$950.00 Million | ▼ -14.1% |
| 2020 | 0.73x | MX$6.20 Billion | MX$8.44 Billion | MX$989.00 Million | ▲ +0.6% |
| 2019 | 0.73x | MX$5.86 Billion | MX$8.02 Billion | MX$1.26 Billion | ▼ -7.2% |
| 2018 | 0.79x | MX$6.62 Billion | MX$8.42 Billion | MX$1.34 Billion | ▲ +15.4% |
| 2017 | 0.68x | MX$4.72 Billion | MX$6.92 Billion | MX$1.54 Billion | ▼ -49.9% |
| 2016 | 1.36x | MX$8.85 Billion | MX$6.50 Billion | MX$2.35 Billion | ▼ -11.4% |
| 2015 | 1.54x | MX$3.95 Billion | MX$2.57 Billion | MX$1.38 Billion | ▲ +25.0% |
| 2014 | 1.23x | MX$6.36 Billion | MX$5.18 Billion | MX$1.19 Billion | ▲ +5.6% |
| 2013 | 1.16x | MX$8.41 Billion | MX$7.22 Billion | MX$1.19 Billion | — |